Physician

Cornelius Robens, M.D.

According to 2025 Medicare claims, Cornelius Robens, M.D. (NPI: 1538158688) practices neurology in the Traverse City, MI market, with the plurality of this provider's patient population coming from Grand Traverse, MI. This provider's primary affiliated billing organization is NOVELLO SPECIALTY CLINIC PC (NPI: 1629716964; TIN: 881663445) and primary practice location at 49684-7306. Robens is affiliated with the Trinity Health Integrated Care (ACO ID: A3454), Honest MSSP of Michigan LLC (ACO ID: A5616), and Northern Michigan Health Network dba NPO-CIN (ACO ID: D0067), participating under both the MSSP and REACH models.

Robens' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 333 traditional Medicare patients, billed 15,398 HCPCS/CPT codes, and received $135,202 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 5,132 prescription claims across 647 beneficiaries totaling $2,755,349 in drug costs, led by Nuplazid (Pimavanserin Tartrate). DME data shows 22 claims. Open Payments data shows 83 records totaling $28,600. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $140,404 to $135,202. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,490 to $14,686.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	583	7,504	$140,404
2016	540	14,393	$161,437
2017	565	19,247	$194,649
2018	541	18,853	$190,478
2019	539	21,029	$189,798
2020	477	22,360	$188,508
2021	443	15,110	$154,643
2022	402	1,461	$58,629
2023	369	5,968	$84,528
2024	333	15,398	$135,202

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	485	4,101	$2,581,525
2016	548	4,203	$2,986,747
2017	567	4,801	$3,884,653
2018	566	4,861	$3,884,124
2019	578	5,143	$3,905,429
2020	609	5,511	$3,867,850
2021	662	5,395	$3,695,874
2022	660	5,368	$3,186,785
2023	662	5,290	$2,991,823
2024	647	5,132	$2,755,349

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	20	$120
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	68	$109,537
2023	N/R	36	$73,776
2024	N/R	22	$68,889

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	50	50	$140
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	244	412	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	48	66	$54
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	141	151	$12
J0585	Injection, onabotulinumtoxina, 1 unit	31	13,350	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nuplazid	Pimavanserin Tartrate	58	1,740	$291,084
Austedo Xr	Deutetrabenazine	24	720	$273,623
Rytary	Carbidopa/Levodopa	112	6,333	$213,976
Austedo	Deutetrabenazine	27	930	$209,303
Vumerity	Diroximel Fumarate	22	660	$182,477

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7340	Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml	N	N/R	11	$55,620
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	11	$13,269

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	83	$28,600	Teva Pharmaceuticals USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Cornelius Robens, M.D.?

Tedicare shows public-source Medicare data for Cornelius Robens, M.D. (NPI 1538158688), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cornelius Robens, M.D. have ACO affiliation data?

Cornelius Robens, M.D. is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454), Honest MSSP of Michigan LLC (MSSP, ACO ID A5616), and Northern Michigan Health Network dba NPO-CIN (REACH, ACO ID D0067).

What billing organization is linked to Cornelius Robens, M.D.?

Cornelius Robens, M.D. is linked to NOVELLO SPECIALTY CLINIC PC (billing NPI 1629716964) in the available physician profile data.

Does Cornelius Robens, M.D. have Open Payments data?

Cornelius Robens, M.D. has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.